Akari Therapeutics Plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Akari Therapeutics Plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2014 to Q2 2024.
  • Akari Therapeutics Plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 23.1M shares, a 14.2% increase year-over-year.
  • Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 21.2M shares, a 19.6% increase from 2022.
  • Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17.7M shares, a 99.6% decline from 2021.
  • Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 4.29B shares, a 35.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 23.1M +2.87M +14.2% Apr 1, 2024 Jun 30, 2024 8-K 2024-09-06
Q1 2024 13.5B +5.98B +80% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 20.3M -5.91B -99.7% Apr 1, 2023 Jun 30, 2023 8-K 2024-09-06
Q1 2023 7.47B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q2 2022 5.93B +2.09B +54.3% Apr 1, 2022 Jun 30, 2022 6-K 2022-09-27
Q2 2021 3.85B Apr 1, 2021 Jun 30, 2021 6-K 2022-09-27
Q2 2019 1.61B +81.4M +5.34% Apr 1, 2019 Jun 30, 2019 6-K 2019-08-29
Q2 2018 1.53B +348M +29.5% Apr 1, 2018 Jun 30, 2018 6-K 2019-08-29
Q2 2017 1.18B 0 0% Apr 1, 2017 Jun 30, 2017 6-K 2018-09-27
Q2 2016 1.18B Apr 1, 2016 Jun 30, 2016 6-K 2017-08-10
Q1 2016 1.18B +455M +63% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q3 2015 782M +708M +965% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-23
Q1 2015 722M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 73.4M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.